butalbital, acetaminophen and caffeine

Generic: butalbital, acetaminophen and caffeine

Labeler: kvk-tech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name butalbital, acetaminophen and caffeine
Generic Name butalbital, acetaminophen and caffeine
Labeler kvk-tech, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetaminophen 325 mg/1, butalbital 50 mg/1, caffeine 40 mg/1

Manufacturer
KVK-Tech, Inc.

Identifiers & Regulatory

Product NDC 10702-253
Product ID 10702-253_11879952-bfdc-4f90-e063-6394a90aae40
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211106
DEA Schedule ciii
Listing Expiration 2026-12-31
Marketing Start 2018-09-26

Pharmacologic Class

Established (EPC)
barbiturate [epc] central nervous system stimulant [epc] methylxanthine [epc]
Chemical Structure
barbiturates [cs] xanthines [cs]
Physiologic Effect
central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10702253
Hyphenated Format 10702-253

Supplemental Identifiers

RxCUI
238154
UNII
362O9ITL9D KHS0AZ4JVK 3G6A5W338E
NUI
N0000175693 M0002177 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name butalbital, acetaminophen and caffeine (source: ndc)
Generic Name butalbital, acetaminophen and caffeine (source: ndc)
Application Number ANDA211106 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
  • 50 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (10702-253-01)
  • 500 TABLET in 1 BOTTLE (10702-253-50)
source: ndc

Packages (2)

Ingredients (3)

acetaminophen (325 mg/1) butalbital (50 mg/1) caffeine (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "11879952-bfdc-4f90-e063-6394a90aae40", "openfda": {"nui": ["N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "KHS0AZ4JVK", "3G6A5W338E"], "rxcui": ["238154"], "spl_set_id": ["7f9c4668-4f4a-453b-b2fa-a6fed903ddfa"], "pharm_class_cs": ["Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "manufacturer_name": ["KVK-Tech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (10702-253-01)", "package_ndc": "10702-253-01", "marketing_start_date": "20180926"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (10702-253-50)", "package_ndc": "10702-253-50", "marketing_start_date": "20181129"}], "brand_name": "Butalbital, Acetaminophen and Caffeine", "product_id": "10702-253_11879952-bfdc-4f90-e063-6394a90aae40", "dosage_form": "TABLET", "pharm_class": ["Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "10702-253", "dea_schedule": "CIII", "generic_name": "Butalbital, Acetaminophen and Caffeine", "labeler_name": "KVK-Tech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Butalbital, Acetaminophen and Caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}], "application_number": "ANDA211106", "marketing_category": "ANDA", "marketing_start_date": "20180926", "listing_expiration_date": "20261231"}